Works matching IS 25233548 AND DT 2021 AND VI 41 AND IP 9

Results: 10

Front Cover: Nuclear Aurora kinase A triggers programmed death‐ligand 1‐mediated immune suppression by activating MYC transcription in triple‐negative breast cancer.
Published in:
Cancer Communications, 2021, v. 41, n. 9, p. i, doi. 10.1002/cac2.12219
By:
- Sun, Shulan;
- Zhou, Wei;
- Li, Xiaoxi;
- Peng, Fei;
- Yan, Min;
- Zhan, Yajing;
- An, Fan;
- Li, Xiaoyan;
- Liu, Yunyong;
- Liu, Quentin;
- Piao, Haozhe
Publication type:
Article
CD70‐targeting CAR‐T cells have potential activity against CD19‐negative B‐cell Lymphoma.
Published in:
Cancer Communications, 2021, v. 41, n. 9, p. 925, doi. 10.1002/cac2.12201
By:
- Deng, Wenhai;
- Chen, Panpan;
- Lei, Wen;
- Xu, Yang;
- Xu, Nengwen;
- Pu, Jeffrey J.;
- Liang, Aibin;
- Qian, Wenbin
Publication type:
Article
Outcomes and toxicities of immune checkpoint inhibitors in colorectal cancer: a real‐world retrospective analysis.
Published in:
Cancer Communications, 2021, v. 41, n. 9, p. 921, doi. 10.1002/cac2.12199
By:
- Zhou, Chengjing;
- Jiang, Ting;
- Li, Rongzhen;
- Yuan, Yan;
- Xie, Weihao;
- Huang, Xiaoxue;
- Wang, Qiaoxuan;
- Chang, Hui;
- Chen, Gong;
- Li, Yuhong;
- Zeng, Zhifan;
- Xiao, Weiwei;
- Gao, Yuanhong
Publication type:
Article
Advancing to the era of cancer immunotherapy.
Published in:
Cancer Communications, 2021, v. 41, n. 9, p. 803, doi. 10.1002/cac2.12178
By:
- Wang, Yun;
- Wang, Min;
- Wu, Hao‐Xiang;
- Xu, Rui‐Hua
Publication type:
Article
Issue Information.
Published in:
Cancer Communications, 2021, v. 41, n. 9, p. 801, doi. 10.1002/cac2.12060
Publication type:
Article
Improving antitumor immunity using antiangiogenic agents: Mechanistic insights, current progress, and clinical challenges.
Published in:
Cancer Communications, 2021, v. 41, n. 9, p. 830, doi. 10.1002/cac2.12183
By:
- Li, Shu‐Jin;
- Chen, Jia‐Xian;
- Sun, Zhi‐Jun
Publication type:
Article
KDELR2 promotes breast cancer proliferation via HDAC3‐mediated cell cycle progression.
Published in:
Cancer Communications, 2021, v. 41, n. 9, p. 904, doi. 10.1002/cac2.12180
By:
- Wei, Haoran;
- Ma, Wenhao;
- Lu, Xiaofei;
- Liu, Haiying;
- Lin, Kashuai;
- Wang, Yinghui;
- Ye, Zijian;
- Sun, Linchong;
- Huang, Zhitong;
- Pan, Tingting;
- Zhou, Zilong;
- Cheng, Eric Y.;
- Zhang, Huafeng;
- Gao, Ping;
- Zhong, Xiuying
Publication type:
Article
Bevacizumab biosimilar LY01008 compared with bevacizumab (Avastin) as first‐line treatment for Chinese patients with unresectable, metastatic, or recurrent non‐squamous non–small‐cell lung cancer: A multicenter, randomized, double‐blinded, phase III trial
Published in:
Cancer Communications, 2021, v. 41, n. 9, p. 889, doi. 10.1002/cac2.12179
By:
- Shi, Yuankai;
- Lei, Kaijian;
- Jia, Yuming;
- Ni, Bingqiang;
- He, Zhiyong;
- Bi, Minghong;
- Wang, Xicheng;
- Shi, Jianhua;
- Zhou, Ming;
- Sun, Qian;
- Wang, Guolei;
- Chen, Dongji;
- Shu, Yongqian;
- Liu, Lianke;
- Guo, Zhongliang;
- Liu, Yong;
- Yang, Junquan;
- Wang, Ke;
- Xiao, Ke;
- Wu, Lin
Publication type:
Article
Nuclear Aurora kinase A triggers programmed death‐ligand 1‐mediated immune suppression by activating MYC transcription in triple‐negative breast cancer.
Published in:
Cancer Communications, 2021, v. 41, n. 9, p. 851, doi. 10.1002/cac2.12190
By:
- Sun, Shulan;
- Zhou, Wei;
- Li, Xiaoxi;
- Peng, Fei;
- Yan, Min;
- Zhan, Yajing;
- An, Fan;
- Li, Xiaoyan;
- Liu, Yunyong;
- Liu, Quentin;
- Piao, Haozhe
Publication type:
Article
Intra‐heterogeneity in transcription and chemoresistant property of leukemia‐initiating cells in murine Setd2<sup>−/−</sup> acute myeloid leukemia.
Published in:
Cancer Communications, 2021, v. 41, n. 9, p. 867, doi. 10.1002/cac2.12189
By:
- Song, Jiachun;
- Du, Longting;
- Liu, Ping;
- Wang, Fuhui;
- Zhang, Bo;
- Xie, Yinyin;
- Lu, Jing;
- Jin, Yi;
- Zhou, Yan;
- Lv, Gang;
- Zhang, Jianmin;
- Chen, Saijuan;
- Chen, Zhu;
- Sun, Xiaojian;
- Zhang, Yuanliang;
- Huang, Qiuhua
Publication type:
Article